What Is Buprenorphine?

Buprenorphine is a partial opioid agonist used for both pain treatment and opioid addiction. Its unique pharmacology offers potential advantages over traditional opioids, including a ceiling effect on respiratory depression and less euphoria. It's increasingly used for chronic pain management.1

How It Works2

  • Partial mu-opioid receptor agonist
  • Kappa receptor antagonist
  • Has a "ceiling effect"
  • High receptor binding affinity
  • Long duration of action

Formulations for Pain

Transdermal Patch (Butrans)

  • Weekly patch
  • 5, 7.5, 10, 15, 20 mcg/hour
  • For moderate to severe chronic pain

Buccal Film (Belbuca)

  • Dissolves in cheek
  • Twice daily dosing
  • Various strengths

Sublingual/Buccal (Suboxone)

  • Often combined with naloxone
  • Primarily for opioid use disorder
  • Sometimes used for pain

Potential Advantages3

  • Lower risk of respiratory depression
  • Less constipation than some opioids
  • May have less abuse potential
  • Stable blood levels (patch)
  • May help patients on high-dose opioids transition
  • Less immunosuppressive

Common Side Effects

  • Nausea (especially starting)
  • Constipation
  • Headache
  • Dizziness
  • Drowsiness
  • Application site reactions (patch)

Important Considerations

  • Schedule III controlled substance
  • Can precipitate withdrawal if started wrong
  • Special prescribing rules may apply
  • Drug interactions exist
  • Not easily reversed with naloxone

Who Might Consider

  • Chronic pain requiring opioids
  • History of opioid misuse concerns
  • Desire to transition from other opioids
  • Poor response to other opioids
  • Medical conditions making other opioids risky

Starting Treatment

  • Requires careful titration
  • May need opioid-free interval first
  • Start low, go slow
  • Provider experienced with buprenorphine helpful

References

  1. Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10(6):209-219.
  2. Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859-870.
  3. Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010;10(5):428-450.